What is a hemangioma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hemangioma: Definition and Classification

A hemangioma is a benign vascular tumor characterized by abnormal proliferation of endothelial cells and aberrant blood vessel architecture, with infantile hemangiomas being the most common benign neoplasm of infancy, occurring in 4-5% of infants. 1

Types of Hemangiomas

Infantile Hemangiomas (IHs)

  • True neoplasms with increased mitotic activity and endothelial cell turnover 1
  • Distinct from vascular malformations which are abnormalities of embryonic development 1
  • Become clinically evident within first few weeks of life
  • Progress through phases of latency, growth, and plateau by first year of life
  • Complete or partial involution by 4 years in 90% of cases (may continue to 8 years) 1

Classification by Soft-Tissue Depth 1

  • Superficial: Red with little/no subcutaneous component (formerly "strawberry" hemangiomas)
  • Deep: Blue and located below skin surface (formerly "cavernous" hemangiomas)
  • Combined (mixed): Both superficial and deep components present

Classification by Anatomic Appearance 1

  • Localized: Well-defined focal lesions (appearing from central point)
  • Segmental: Involving an anatomic region, often plaque-like, >5 cm in diameter
  • Indeterminate: Neither clearly localized nor segmental
  • Multifocal: Multiple discrete hemangiomas at different sites

Clinical Characteristics

Risk Factors for Infantile Hemangiomas 1

  • Prematurity
  • White race (3-10%)
  • Female sex (female:male ratio 1.4:1 to 3:1)

Natural History

  • Most infantile hemangiomas are diagnosed clinically 1
  • Typical growth pattern: rapid proliferation followed by gradual involution 1
  • Immunohistochemically stain positive for erythrocyte-type glucose transporter protein 1

Locations

  • Can occur in any organ of the human body 2
  • Common locations include skin, soft tissues, liver, and rarely airway
  • Airway hemangiomas most commonly localized in subglottic airway 1

Diagnostic Considerations

When Imaging Is Indicated 1

  • Superficial lesions with atypical features
  • Deep lesions difficult to assess physically
  • Central or segmental location in face/ears, breast, midline lumbosacral region
  • Lesions ≥4 cm
  • Presence of ≥5 hemangiomas
  • Rapid growth rate

Imaging Characteristics

  • MRI: Preferred modality for detailed evaluation 3
  • Liver hemangiomas: Typically hyperintense on T2-weighted MRI with centripetal filling pattern after contrast 2
  • CEUS (Contrast Enhanced Ultrasound): For liver hemangiomas - peripheral nodular enhancement (74%) in arterial phase and complete (78%) or incomplete (22%) centripetal filling in portal venous and late phases 1

Associated Conditions

PHACE Syndrome 1

  • Posterior fossa malformations
  • Hemangioma
  • Arterial anomalies
  • Coarctation of aorta/cardiac defects
  • Eye abnormalities

Kasabach-Merritt Phenomenon (KMP) 3

  • Important distinction: KMP occurs exclusively with kaposiform hemangioendothelioma or tufted angioma, NOT with common infantile hemangiomas
  • Characterized by life-threatening consumptive coagulopathy with profound thrombocytopenia and hypofibrinogenemia

Management Considerations

Treatment Indications

  • Most hemangiomas are small, nonproblematic, and can be managed conservatively 4
  • Treatment indicated for symptomatic lesions with:
    • Ulceration
    • Bleeding
    • Vision disturbances
    • Functional limitations
    • Disfigurement

Treatment Options for Infantile Hemangiomas 1, 3

  • First-line: Propranolol (1-3 mg/kg/day divided into 2-3 doses)
  • Alternative: Oral corticosteroids (prednisolone/prednisone 2-3 mg/kg/day)
  • Topical: Timolol for thin/superficial IHs
  • Procedural: Laser therapy for early lesions, focal lesions, or residual telangiectasias
  • Surgical: Most useful for treatment of residual skin changes after involution

Liver Hemangiomas 5

  • Most common benign liver tumors
  • Observation justified for asymptomatic giant liver hemangiomas (>5 cm)
  • Surgical resection indicated for:
    • Abdominal (mechanical) complaints
    • Complications
    • Inconclusive diagnosis
  • Enucleation is the preferred surgical method

Special Considerations

Pregnancy 1

  • Hemangiomas can increase in size during pregnancy
  • Most pregnancies with hemangiomas do not develop complications
  • Risk of hepatic rupture in giant (>4 cm) liver hemangioma is 3.2%
  • Risk increases to 5% in lesions >10 cm
  • Close monitoring recommended during pregnancy

Common Pitfalls

  • Historical terms like "cavernous hemangioma" and "venous hemangioma" have contributed to diagnostic confusion 3
  • Atypical features in high-flow hemangiomas can be mistaken for hepatocellular carcinomas or focal nodular hyperplasia 1
  • Important to differentiate hemangiomas from other vascular anomalies as management approaches differ significantly 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hemangioma from head to toe: MR imaging with pathologic correlation.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2004

Guideline

Vascular Anomalies and Kasabach-Merritt Phenomenon

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hemangioma: Recent Advances.

F1000Research, 2019

Research

Management of giant liver hemangiomas: an update.

Expert review of gastroenterology & hepatology, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.